HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae-Cheon Kang Selected Research

neurofilament protein H

12/2005Transient ischemia-induced changes of neurofilament 200 kDa immunoreactivity and protein content in the main olfactory bulb in gerbils.
3/2005Chronological changes of neurofilament 200 kDa immunoreactivity in the lateral olfactory tract after transient forebrain ischemia in gerbils.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tae-Cheon Kang Research Topics

Disease

45Status Epilepticus (Complex Partial Status Epilepticus)
05/2022 - 03/2007
44Ischemia
02/2014 - 01/2002
28Epilepsy (Aura)
03/2022 - 01/2003
23Edema (Dropsy)
11/2020 - 10/2010
11Seizures (Absence Seizure)
04/2021 - 11/2002
6Inflammation (Inflammations)
12/2011 - 05/2009
5Necrosis
02/2021 - 04/2007
5Gliosis
10/2020 - 03/2010
5Stroke (Strokes)
04/2010 - 11/2004
5Nervous System Diseases (Neurological Disorders)
05/2008 - 12/2004
4Temporal Lobe Epilepsy
03/2022 - 10/2008
4Neoplasms (Cancer)
01/2019 - 12/2006
3Neuroinflammatory Diseases
01/2020 - 08/2014
3Burns
08/2016 - 03/2011
3Alcoholism (Alcohol Abuse)
09/2014 - 10/2009
3Parkinson Disease (Parkinson's Disease)
06/2012 - 07/2002
3Shock
06/2012 - 03/2008
3Brain Ischemia (Cerebral Ischemia)
06/2005 - 11/2004
2Breast Neoplasms (Breast Cancer)
06/2015 - 03/2009
2Infections
04/2010 - 01/2009
2Brain Injuries (Brain Injury)
04/2010 - 02/2005
2Hypoxia (Hypoxemia)
04/2007 - 08/2006
2Spinal Cord Ischemia
06/2005 - 10/2004
2Reperfusion Injury
02/2005 - 11/2004
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2003 - 01/2003
1Drug Resistant Epilepsy
08/2021
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
04/2021 - 06/2004
13Pilocarpine (Ocusert)FDA LinkGeneric
04/2021 - 10/2006
10AcidsIBA
05/2022 - 12/2007
10salicylhydroxamic acid (SHAM)IBA
04/2007 - 01/2002
9EnzymesIBA
12/2011 - 07/2002
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 03/2011
7CalciumIBA
07/2006 - 02/2004
6bardoxolone methylIBA
05/2022 - 01/2019
6Glutamic Acid (Glutamate)FDA Link
04/2021 - 06/2002
6AntioxidantsIBA
01/2019 - 11/2004
6Glial Fibrillary Acidic ProteinIBA
01/2018 - 10/2003
5ParvalbuminsIBA
02/2021 - 04/2004
5p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 09/2015
5DystrophinIBA
11/2019 - 11/2010
5CytokinesIBA
04/2012 - 10/2010
5gamma-Aminobutyric Acid (GABA)IBA
05/2011 - 07/2002
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2010 - 11/2004
5Adenosine Triphosphatases (ATPase)IBA
07/2005 - 01/2002
4Phosphotransferases (Kinase)IBA
04/2021 - 10/2010
4Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2020 - 05/2008
4Purinergic P2X7 ReceptorsIBA
06/2012 - 10/2010
4Neuroprotective AgentsIBA
08/2006 - 09/2004
4CalbindinsIBA
06/2005 - 05/2003
3GYKI 52466IBA
08/2021 - 12/2020
3AMPA Receptors (AMPA Receptor)IBA
08/2021 - 12/2020
3perampanelIBA
08/2021 - 12/2020
3HMGB1 Protein (HMG1)IBA
02/2021 - 01/2016
3Caspase 3 (Caspase-3)IBA
02/2021 - 04/2007
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2020 - 04/2006
3Aquaporin 4IBA
11/2020 - 08/2011
3Laminin ReceptorsIBA
11/2020 - 01/2019
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 08/2011
3TRPC6 Cation ChannelIBA
11/2019 - 08/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 11/2016
3Vitamin B 6IBA
05/2008 - 05/2005
3Superoxide Dismutase-1IBA
05/2006 - 11/2004
2EstersIBA
05/2022 - 01/2019
2Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2021 - 01/2018
2TensinsIBA
04/2021 - 12/2020
2Aquaporins (Water Channels)IBA
11/2020 - 03/2011
2Threonine (L-Threonine)FDA Link
09/2019 - 01/2012
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
09/2019 - 11/2016
2Protein Kinase CIBA
01/2019 - 12/2018
2leptomycin BIBA
09/2017 - 11/2016
2BQ 788IBA
11/2016 - 09/2015
2Endothelins (Endothelin)IBA
11/2016 - 01/2013
24- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
11/2016 - 09/2015
2Lim KinasesIBA
01/2016 - 10/2015
2Endothelin-1 (Endothelin 1)IBA
10/2015 - 08/2011
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2015 - 06/2015
2Pharmaceutical PreparationsIBA
06/2015 - 03/2010
2Adenylyl Cyclases (Adenylyl Cyclase)IBA
09/2014 - 01/2006
2Levetiracetam (Keppra)FDA LinkGeneric
06/2013 - 03/2010
2Valproic Acid (Depakote)FDA LinkGeneric
06/2013 - 03/2010
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2012 - 05/2008
2NF-kappa B (NF-kB)IBA
12/2011 - 10/2010
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2011 - 03/2011
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2011 - 03/2011
2Interleukin-6 (Interleukin 6)IBA
05/2011 - 03/2011
2Biomarkers (Surrogate Marker)IBA
10/2009 - 03/2009
2Calcium-Binding ProteinsIBA
07/2007 - 02/2004
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2006 - 03/2005
2alpha-SynucleinIBA
08/2006 - 07/2002
2Ceruloplasmin (Ferroxidase)IBA
06/2006 - 06/2004
2neurofilament protein HIBA
12/2005 - 03/2005
2Potassium Channels (Potassium Channel)IBA
01/2005 - 10/2004
2GalaninIBA
01/2005 - 10/2004
2Corticotropin-Releasing HormoneIBA
07/2003 - 01/2003
1Glutathione (Reduced Glutathione)IBA
04/2022
1Casein Kinase II (Casein Kinase 2)IBA
04/2021
1Actins (F Actin)IBA
01/2021
1S 10 (S-10)IBA
01/2021

Therapy/Procedure

6Therapeutics
02/2013 - 12/2006